Filters

anti-CEACAM21 Antibody

anti-CEACAM21 Antibody size: 200ug (50ug, 100ug available) 465

Price 465
Size 200ug (50ug, 100ug available)
The antibodie's descriptionanti- Carcinoembryonic antigen-related cell adhesion molecule 21 antibody
The antigen usedepitope of the human Carcinoembryonic antigen-related cell adhesion molecule 21 antigen
Gene nameCarcinoembryonic antigen-related cell adhesion molecule 21
Reactivityhuman
Research fieldIntermediates
Related productsCEACAM21 rabbit polyclonal antibodies
Description Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4°
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bluegen antibodies they should be stored frozen at - 24°
Gene targetCEACAM21
Short nameanti-CEACAM21 Antibody
Technique antibodies against human proteins, antibodies for, antibody to, Antibody
Alternative nameantibody to-carcinoembryonic protein-related cellular adhesion molecule 21 (Antibody to)
Alternative techniqueantibodies
Alternative to gene target CEACAM21 and IDBG-53114 and ENSG00000007129 and 90273, Plasma membranes, protein binding, this GO :0005515 and protein binding and molecular function this GO :0016021 and integral component of membrane and cellular component, this GO :0005515: protein binding, this GO :0005515: protein binding, carcinoembryonic antigen-related cell adhesion molecule 21
Identity 28834
Gene CEACAM21
Long gene name carcinoembryonic antigen related cell adhesion molecule 21
Synonyms gene name carcinoembryonic antigen-related cell adhesion molecule 21
Synonyms R29124_1 FLJ13540
Locus 19q13, 2
Discovery year 2005-07-25
GenBank acession AK023602
Entrez gene record 90273
Pubmed identfication 12477932
RefSeq identity NM_033543
Classification Immunoglobulin like domain containing V-set domain containing Carcinoembryonic antigen related cell adhesion molecule family
Havana BLAST/BLAT OTTHUMG00000151062

Subscribe to our Newsletter